EP0244427A4 - RECOMBINANT VIRUS. - Google Patents

RECOMBINANT VIRUS.

Info

Publication number
EP0244427A4
EP0244427A4 EP19860905164 EP86905164A EP0244427A4 EP 0244427 A4 EP0244427 A4 EP 0244427A4 EP 19860905164 EP19860905164 EP 19860905164 EP 86905164 A EP86905164 A EP 86905164A EP 0244427 A4 EP0244427 A4 EP 0244427A4
Authority
EP
European Patent Office
Prior art keywords
recombinant virus
recombinant
virus
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP19860905164
Other languages
German (de)
English (en)
French (fr)
Other versions
EP0244427A1 (en
Inventor
Christopher John Langford
Stirling John Edwards
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Saramane Pty Ltd
Original Assignee
Walter and Eliza Hall Institute of Medical Research
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Walter and Eliza Hall Institute of Medical Research filed Critical Walter and Eliza Hall Institute of Medical Research
Publication of EP0244427A1 publication Critical patent/EP0244427A1/en
Publication of EP0244427A4 publication Critical patent/EP0244427A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C07K14/445—Plasmodium
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/62—DNA sequences coding for fusion proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/61—Fusion polypeptide containing an enzyme fusion for detection (lacZ, luciferase)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/24011—Poxviridae
    • C12N2710/24111—Orthopoxvirus, e.g. vaccinia virus, variola
    • C12N2710/24141—Use of virus, viral particle or viral elements as a vector
    • C12N2710/24143—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
EP19860905164 1985-08-29 1986-08-29 RECOMBINANT VIRUS. Withdrawn EP0244427A4 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
AUPH219885 1985-08-29
AU2198/85 1985-08-29

Publications (2)

Publication Number Publication Date
EP0244427A1 EP0244427A1 (en) 1987-11-11
EP0244427A4 true EP0244427A4 (en) 1989-04-27

Family

ID=3771250

Family Applications (1)

Application Number Title Priority Date Filing Date
EP19860905164 Withdrawn EP0244427A4 (en) 1985-08-29 1986-08-29 RECOMBINANT VIRUS.

Country Status (11)

Country Link
EP (1) EP0244427A4 (da)
JP (1) JPS63500637A (da)
KR (1) KR880700073A (da)
AU (1) AU594087B2 (da)
DK (1) DK219187D0 (da)
ES (1) ES2002128A6 (da)
FI (1) FI871885A0 (da)
IL (1) IL79880A0 (da)
NZ (1) NZ217400A (da)
WO (1) WO1987001386A1 (da)
ZA (1) ZA866582B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5182211A (en) * 1987-08-07 1993-01-26 Institut Pasteur Plasmid vectors encoding a protein of a picornavirus
AU626288B2 (en) * 1988-02-05 1992-07-30 Commonwealth Scientific And Industrial Research Organisation Gene expression system (particularly for rotavirus vp7 protein) involving a foreign signal peptide and optionally a transmembrane anchor sequence
FR2663228A2 (fr) * 1989-09-29 1991-12-20 Agronomique Inst Nat Rech Composition immunisante contre la maladie de newcastle et procede de preparation.
US8101189B2 (en) 2002-07-05 2012-01-24 Folia Biotech Inc. Vaccines and immunopotentiating compositions and methods for making and using them
ES2431963T3 (es) 2002-07-05 2013-11-28 Folia Biotech Inc. Partícula viral adyuvante

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1984002917A1 (en) * 1983-01-28 1984-08-02 Inst Medical W & E Hall EXPRESSION OF PLASMODIUM FALCIPARUM POLYPEPTIDES FROM CLONED cDNA

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2442271A1 (fr) * 1978-11-27 1980-06-20 Pasteur Institut Vecteur permettant l'insertion d'un gene procaryote ou eucaryote, et l'excretion de la proteine exprimee
US4603112A (en) * 1981-12-24 1986-07-29 Health Research, Incorporated Modified vaccinia virus
US4593002A (en) * 1982-01-11 1986-06-03 Salk Institute Biotechnology/Industrial Associates, Inc. Viruses with recombinant surface proteins
AU570940B2 (en) * 1982-11-30 1988-03-31 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Process for producing poxvirus recombinants for expression offoreign genes
EP0162738A1 (en) * 1984-04-09 1985-11-27 MOLECULAR GENETICS RESEARCH & DEVELOPMENT LIMITED PARTNERSHIP Production of pseudorabies virus subunit vaccines
FR2563434B1 (fr) * 1984-04-25 1986-07-25 Transgene Sa Vaccin contre la rage et procede pour sa preparation

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1984002917A1 (en) * 1983-01-28 1984-08-02 Inst Medical W & E Hall EXPRESSION OF PLASMODIUM FALCIPARUM POLYPEPTIDES FROM CLONED cDNA

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
MOLECULAR AND CELLULAR BIOLOGY, vol. 6, no. 9, September 1986, pages 3191-3199, American Society for Microbiology; C.J. LANGFORD et al.: "Anchoring a secreted plasmodium antigen on the surface of recombinant vaccinia virus-infected cells increases its immunogenicity" *
NEW APPROACHES TO IMMUNIZATION: DEVELOPING VACCINES AGAINST PARASITIC, BACTERIAL AND VIRAL DISEASES; CONFERENCE ON VACCINES 86, pages 145-148, Cold Spring Harbor Laboratory, New York, US; C.J. LANGFORD et al.: "Antigens of the asexual blood stages of Plasmodium falciparum and their expression in recombinant vaccinia virus" *
See also references of WO8701386A1 *

Also Published As

Publication number Publication date
DK219187A (da) 1987-04-29
EP0244427A1 (en) 1987-11-11
FI871885L (fi) 1987-04-29
AU6370186A (en) 1987-03-24
KR880700073A (ko) 1988-02-15
IL79880A0 (en) 1986-11-30
WO1987001386A1 (en) 1987-03-12
FI871885A7 (fi) 1987-04-29
JPS63500637A (ja) 1988-03-10
FI871885A0 (fi) 1987-04-29
DK219187D0 (da) 1987-04-29
AU594087B2 (en) 1990-03-01
ES2002128A6 (es) 1988-07-16
NZ217400A (en) 1989-09-27
ZA866582B (en) 1987-04-29

Similar Documents

Publication Publication Date Title
DE3585158D1 (en) Muenzauswahlvorrichtung.
DE3577824D1 (en) Blaettersortierer.
DE3585028D1 (en) Koerperpflegemittel.
DE3670494D1 (en) Wasserloesliche photoinitiatoren.
DE3669099D1 (en) Schaedelschraube.
AU1628895A (en) Recombinant virus
DE3668780D1 (en) Intubationsvorrichtung.
GB8821528D0 (en) Recombinant vaccinia virus
DE3683186D1 (de) Rekombinantes humaninterleukin-1.
DE3668820D1 (en) Reibschweissgeraet.
EP0218717A4 (en) RECOMBINANT INHIBIN.
DE3676421D1 (en) Copolyester.
EP0249611A4 (en) T-LYMPHOTROPHIC VIRUS.
DE3670950D1 (en) Epicondylitis-bandage.
DE3668894D1 (en) Erythromycin-derivate.
OA08200A (en) Vaccine.
OA08199A (en) Vaccine.
DE3670576D1 (en) Wuerfelspiel.
DE3669521D1 (en) Thermoplastische polycarbonatformmassen.
DE3668698D1 (en) Waegeapparat.
DE3670439D1 (en) Trennbares extraorales orthodontisches geraet.
GR3034271T3 (en) Pseudorabies virus protein.
DE3667662D1 (en) Pyrazinderivate.
DE3670503D1 (en) Thermoplastische polycarbonatformmassen.
DE3670585D1 (en) Strangfuehrung.

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 19870502

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AT BE CH DE FR GB IT LI LU NL SE

A4 Supplementary search report drawn up and despatched

Effective date: 19890427

17Q First examination report despatched

Effective date: 19901025

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: SARAMANE PTY. LTD.

18D Application deemed to be withdrawn

Effective date: 19920303

RIN1 Information on inventor provided before grant (corrected)

Inventor name: LANGFORD, CHRISTOPHER, JOHN

Inventor name: EDWARDS, STIRLING, JOHN